A detailed history of Buffington Mohr Mc Neal transactions in Merck & Co., Inc. stock. As of the latest transaction made, Buffington Mohr Mc Neal holds 82,787 shares of MRK stock, worth $10.5 Million. This represents 1.98% of its overall portfolio holdings.

Number of Shares
82,787
Previous 76,746 7.87%
Holding current value
$10.5 Million
Previous $8.37 Million 30.56%
% of portfolio
1.98%
Previous 1.68%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$113.24 - $131.95 $684,082 - $797,109
6,041 Added 7.87%
82,787 $10.9 Million
Q4 2023

Jan 30, 2024

BUY
$100.18 - $109.02 $32,859 - $35,758
328 Added 0.43%
76,746 $8.37 Million
Q3 2023

Oct 25, 2023

SELL
$102.95 - $114.33 $144,644 - $160,633
-1,405 Reduced 1.81%
76,418 $7.87 Million
Q2 2023

Jul 25, 2023

SELL
$108.61 - $118.38 $368,513 - $401,663
-3,393 Reduced 4.18%
77,823 $8.98 Million
Q1 2023

Apr 26, 2023

BUY
$102.94 - $114.86 $112,101 - $125,082
1,089 Added 1.36%
81,216 $8.64 Million
Q4 2022

Jan 19, 2023

SELL
$87.44 - $112.11 $168,322 - $215,811
-1,925 Reduced 2.35%
80,127 $0
Q3 2022

Oct 11, 2022

BUY
$84.53 - $94.96 $145,391 - $163,331
1,720 Added 2.14%
82,052 $7.07 Million
Q2 2022

Jul 19, 2022

BUY
$83.49 - $94.64 $24,546 - $27,824
294 Added 0.37%
80,332 $7.32 Million
Q1 2022

May 02, 2022

BUY
$73.51 - $82.4 $182,672 - $204,764
2,485 Added 3.2%
80,038 $6.57 Million
Q4 2021

Jan 27, 2022

BUY
$72.28 - $90.54 $89,771 - $112,450
1,242 Added 1.63%
77,553 $5.94 Million
Q3 2021

Oct 13, 2021

BUY
$71.68 - $78.83 $184,719 - $203,144
2,577 Added 3.49%
76,311 $5.73 Million
Q2 2021

Jul 28, 2021

BUY
$70.31 - $77.77 $284,896 - $315,124
4,052 Added 5.81%
73,734 $5.73 Million
Q1 2021

Apr 14, 2021

BUY
$68.86 - $81.11 $3.85 Million - $4.54 Million
55,957 Added 407.7%
69,682 $5.37 Million
Q4 2020

Jan 20, 2021

BUY
$71.77 - $79.65 $151,721 - $168,380
2,114 Added 18.21%
13,725 $1.12 Million
Q3 2020

Oct 26, 2020

BUY
$73.18 - $82.95 $95,060 - $107,752
1,299 Added 12.6%
11,611 $963,000
Q2 2020

Jul 27, 2020

BUY
$70.42 - $80.13 $100,841 - $114,746
1,432 Added 16.13%
10,312 $797,000
Q1 2020

Apr 08, 2020

BUY
$63.36 - $87.82 $137,491 - $190,569
2,170 Added 32.34%
8,880 $683,000
Q3 2019

Oct 10, 2019

SELL
$76.08 - $82.93 $26,628 - $29,025
-350 Reduced 4.96%
6,710 $565,000
Q2 2019

Jul 31, 2019

SELL
$69.84 - $81.59 $18,577 - $21,702
-266 Reduced 3.63%
7,060 $592,000
Q1 2019

Apr 29, 2019

SELL
$69.58 - $79.36 $2,087 - $2,380
-30 Reduced 0.41%
7,326 $609,000
Q4 2018

Feb 07, 2019

BUY
$65.24 - $75.71 $15,200 - $17,640
233 Added 3.27%
7,356 $562,000
Q2 2018

Jul 30, 2018

BUY
$50.83 - $59.72 $362,062 - $425,385
7,123 New
7,123 $432,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $320B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Buffington Mohr Mc Neal Portfolio

Follow Buffington Mohr Mc Neal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Buffington Mohr Mc Neal, based on Form 13F filings with the SEC.

News

Stay updated on Buffington Mohr Mc Neal with notifications on news.